- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased hematocrit / IMPC
- increased leukocyte cell number / IMPC
- increased mean platelet volume / IMPC
- decreased circulating triglyceride level / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating chloride level / IMPC
- thrombocytopenia / IMPC
- increased lean body mass / IMPC
- decreased circulating iron level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating bilirubin level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating glucose level / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- decreased circulating total protein level / IMPC
- increased circulating sodium level / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- increased circulating amylase level / IMPC
- decreased total body fat amount / IMPC
- increased red blood cell distribution width / IMPC
C57BL/6N-Slc29a3em1(IMPC)Wtsi/WtsiCnrm
Status | Available to order |
EMMA ID | EM:13448 |
International strain name | C57BL/6N-Slc29a3em1(IMPC)Wtsi/WtsiCnrm |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Slc29a3em1(IMPC)Wtsi |
Gene/Transgene symbol | Slc29a3 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- H syndrome / Orphanet_168569
- Dysosteosclerosis / Orphanet_1782
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal liver morphology / IMPC
- increased lean body mass / IMPC
- small uterus / IMPC
- enlarged liver / IMPC
- abnormal stomach morphology / IMPC
- decreased circulating HDL cholesterol level / IMPC
- hyperplasia / IMPC
- decreased erythrocyte cell number / IMPC
- abnormal lymph node morphology / IMPC
- increased spleen weight / IMPC
- enlarged spleen / IMPC
- enlarged lymph nodes / IMPC
- increased circulating chloride level / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- abnormal uterus morphology / IMPC
- enlarged duodenum / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating aspartate transaminase level / IMPC
- small kidney / IMPC
- prolonged RR interval / IMPC
- decreased circulating cholesterol level / IMPC
- increased red blood cell distribution width / IMPC
- increased startle reflex / IMPC
- enlarged ileum / IMPC
- abnormal skin morphology / IMPC
- abnormal kidney morphology / IMPC
- increased circulating alanine transaminase level / IMPC
- abnormal thymus morphology / IMPC
- abnormal cecum morphology / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- fibrosis / IMPC
- atrophy / IMPC
- abnormal brain morphology / IMPC
- decreased total body fat amount / IMPC
- abnormal spleen morphology / IMPC
- increased circulating sodium level / IMPC
- small seminal vesicle / IMPC
- abnormal lung morphology / IMPC
- distended jejunum / IMPC
- increased circulating amylase level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating total protein level / IMPC
- increased circulating bilirubin level / IMPC
- abnormal seminal vesicle morphology / IMPC
- decreased hemoglobin content / IMPC
- decreased circulating LDL cholesterol level / IMPC
- thrombocytopenia / IMPC
- enlarged cecum / IMPC
- abnormal caudal vertebrae morphology / IMPC
- decreased hematocrit / IMPC
- increased mean platelet volume / IMPC
- decreased heart rate / IMPC
- decreased circulating glucose level / IMPC
- increased leukocyte cell number / IMPC
- small thymus / IMPC
- increased liver weight / IMPC
- decreased circulating serum albumin level / IMPC
- decreased body length / IMPC
- abnormal colon morphology / IMPC
MGI phenotypes (gene matching)
- extramedullary hematopoiesis / MGI
- enlarged spleen / MGI
- enlarged lymph nodes / MGI
- premature death / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal macrophage morphology / MGI
- abnormal macrophage physiology / MGI
- abnormal lysosome physiology / MGI
- immune system phenotype / MGI
- increased macrophage cell number / MGI
- increased histiocytic sarcoma incidence / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
- myeloid hyperplasia / MGI
- increased macrophage apoptosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).